HIGHLIGHTS
- who: Igor Latorzeff and collaborators from the University Hospitals Cleveland Medical Center, United States have published the research work: Use of a Biodegradable, Contrast-Filled Rectal Spacer Balloon in Intensity-Modulated Radiotherapy for Intermediate-Risk Prostate Cancer Patients: Dosimetric Gains in the BioPro-RCMI-1505 Study, in the Journal: (JOURNAL)
- what: There were no intergroup differences in the incidence of acute grade ≥2 When considering the primary objective, the authors found that use of the balloon spacer resulted in statistically significant dosimetric gains for the rectum. This study had a number of limitations.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.